Osteopontin is a therapeutic target that drives breast cancer recurrence
Yu Gu(McGill University Health Centre), William J. Muller(McGill University Health Centre)
Cited by 28
Related Papers
Oncogenes and Tumor Suppressor Genes
|Cold Spring Harbor Perspectives in Biology|2010|504
ShcA signalling is essential for tumour progression in mouse models of human breast cancer
|The EMBO Journal|2008|159
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
|Nature Communications|2018|84
PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis
|Journal of Biological Chemistry|2009|78
Targeting fatty acid oxidation enhances response to HER2-targeted therapy
|Nature Communications|2024|50